Dr Joseph Tomson
MD 2016, CCT Cardiology 2015, MRCP Royal College of Physicians 2004
Dr J Tomson qualified as a physician in 1999 and completed specialist Cardiology training in the WM Deanery, UK (CCT) in 2015. He also undertook Cardiovascular research, trials and epidemiology training at the University of Oxford where he completed his doctorate (MD).
He is a Consultant Cardiologist based at the Royal Free London Hospitals and consults privately in London. He has interests in Cardiovascular disease especially in disorders relating to cardiac rhythm, cardiac dysfunction, coronary disease and in cardiovascular disease prevention.
Dr Tomson’s specialist interests include cardiac rhythm management, cardiac device therapy (cardiac resynchronisation therapy, pacemakers, implantable cardiac defibrillators), heart failure, cardiomyopathies, palpitations and syncope.
He also has expertise in cardiovascular imaging, cardiovascular research including epidemiology and drug trials. He is a Member of the Royal College of Physicians, UK (MRCP), and is a Certified Cardiac Device Specialist (CCDS) by the IBHRE. He conducts cardiovascular research and teaches medical students at the UCL, London.
- Implant of cardiac pacemakers
- Cardiac defibrillators
- Resynchronization therapy devices
- Heart rhythm monitors; diagnostic coronary angiography
- Cardiac Rhythm management
- Management of palpitations
- Loss of conciousness or syncope
- Implant of cardiac devices
- Heart failure
- Cardiac defibrillator
- Cardiac resynchronisation therapy
- Atrial fibrillation
- Breathlessness of cardiac cause
- Coronary disease
- Cardiovascular diseases
- Prevention of cardiovascular disease
- Cardiac problems with chronic illnesses
- Cardiovascular research
- Cardiovascular disease
- Cardiac function
- Clinical studies on devices
- Cardiac rhythms
- Arterial stiffness
- CVD epidemiology
- Clinical evidence through Randomised controlled trials
- Developing International research collaborations
- Public health
- Healthcare innovation
Tomson J, et al. Effects of vitamin D on blood pressure, arterial stiffness and cardiac function in older people after 1 year: BEST-D trial. J Am Heart Assoc. 2017 Oct 24;6(10)
HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med. 2017 Sep 28;377(13):1217-1227
Tomson J, Emberson J, Hill M, et al. Vitamin D and risk of death from vascular and nonvascular causes in the Whitehall study and meta-analyses of 12,000 deaths. European Heart journal. 2013 May;34(18):136574.
Tomson J, Bowman L, Armitage J. Concise guide to recommended lipid lowering drug treatment. Prescriber. 2011.
Rezk T, Whelan CJ, … Tomson J, et al. Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis. Br J Haematol. 2017 May 9.